Alpha-Tec Joins Life Science Holding Group
Vancouver, Washington – Alpha-Tec Systems announces today its new partnership with Life Science Holding Group, a subsidiary of StoneCalibre. Life Science Holding includes leaders in Proteomics, Genomics, Molecular, and now with the addition of Alpha-Tec, In-Vitro Diagnostics.
“We are please to welcome Alpha-Tec to the StoneCalibre family,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “Alpha-Tec has maintained a first-class reputation in the mycobacteriology space for over 35 years. We are excited to partner with a company that enables the global medical community to accurately diagnose and timely treat infectious diseases, such as latent tuberculosis, to help elevate the quality of human life.”
Alpha-Tec will maintain producing its full range of established products for mycobacteriology, parasitology, bacteriology and mycology diagnostics, and customer service, as well as global health, will continue to be the focus of its mission.
“Alpha-Tec has a proud history of being a family-run business with exceptional customer service.” said Chris Williams, Chief Executive Officer of Alpha-Tec. “As we move forward toward the next phase in the Company’s evolution, it is important for us to partner with someone who understands our history and shares our vision for Alpha-Tec’s future. We are therefore very excited to join with StoneCalibre and its affiliates in the life sciences. Drawing from their knowledge of the industry, operational resources, and geographic reach will contribute greatly toward accelerating Alpha-Tec’s growth going forward and will further advance our broader mission of improving patient care through diagnostics.”